Fingerprint
Dive into the research topics of 'Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: Results from a phase 2 randomised, parallel group, placebo-controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically